Media
Press releases
-
AlzeCure abstract on NeuroRestore ACD856 accepted at the Alzheimer’s conference AP/PD 2026
February 3, 2026
-
AlzeCure Pharma selected to present at the Bio-Neuroscience conference in Amsterdam
February 2, 2026
-
AlzeCure receives payment of EU grant for Phase 2 clinical trial with NeuroRestore ACD856 for Alzheimer’s disease
December 3, 2025